Current licensing opportunities
Using hPSCs as a source of human amnion-like cells provides a standardised, inexpensive and potentially unlimited source of amnion cells
This novel technology can simultaneously profile multiple histone modifications and transcriptomes, at single-cell resolution
Increased acetyl-coA flux in the lipid synthesis & fatty acid oxidation pathways could lead to treatments for metabolic/age-related diseases